GLP-1 drugs (like Ozempic and Mounjaro) are a case study in whats possible when you tackle giant markets that people truly care about
eClinicalMedicine 72, 102624
Among the 56 patients with complete follow-up data at 1 year, there was a significant improvement in weight-related comorbidities, including a reduction in obstructive sleep apnea syndrome ( 30%), hypertension ( 40%), arthralgia ( 56.5%), and fatty liver disease ( 36.4%)
Here are the main differences: Cost and convenience
Second, confirm the exact medication and fulfillment pathway before completing any payment, to ensure the product received matches what was expected
While some weight regain is possible after stopping any weight loss medication, patients who maintain healthy eating habits and regular exercise typically keep most of their weight off